Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid LeukemiaYi‐Bin Chen, Robert J. Soiffer, Corey Cutler et al.|Biology of Blood and Marrow Transplantation|2014Cited by 234
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with <i> <scp>FLT</scp> 3 </i> ‐ <scp>ITD</scp> acute myeloid leukaemia in first complete remissionAndrew M. Brunner, Yi‐Bin Chen, Sarah Nikiforow et al.|British Journal of Haematology|2016Cited by 174